Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
First Watch Restaurant Group, Inc. Reports Preliminary Operational Metrics for the Fourth Quarter and Fiscal Year 2025
-
Relmada Therapeutics Provides Regulatory Update Confirming FDA Alignment on Registrational Studies Design for NDV-01 for Two Separate Indications
-
Tessera Therapeutics Announces FDA Clearance of IND Application for its Lead In Vivo Gene Editing Program TSRA-196 for AATD
-
BioCryst Announces Preliminary Full Year 2025 ORLADEYO® (berotralstat) Net Revenue of $601 Million (+37 percent y-o-y), Beating Prior Guidance Range
-
Zumiez Inc. Reports Holiday 2025 Sales Results
-
Noodles & Company Announces Preliminary Revenue Results for the Fourth Quarter of 2025
-
Emerita Resources Provides Corporate Update
-
Skye Provides 2026 Corporate Outlook
-
Protara Therapeutics Highlights Recent Updates and Anticipated 2026 Milestones
-
Lexeo Therapeutics Announces Positive Interim Phase I/II Data for LX2020 for the Treatment of PKP2-Associated Arrhythmogenic Cardiomyopathy
-
Highwoods Announces Investment Activity
-
BioXcel Therapeutics Expands Leadership Team to Prepare for Launch of IGALMI® in the At-Home Setting
-
Sable Announces Director Change
-
Coppernico Defines 155 m of Continuous Copper Mineralization Averaging 0.54% at Sombrero’s Nioc Target
-
Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 44th Annual J.P. Morgan Healthcare Conference
-
K Wave Media Leads Investment in “Once We Were Us,” Now the #1 Film at the Korean Box Office
-
Sharps Technology and Coinbase Expand Relationship with Launch of Institutional-Grade Solana Validator
-
Annexon Accelerating Next Generation Targeted Immunotherapy Platform for Treatment of Neuroinflammatory Diseases with Multiple Registrational Milestones in 2026
-
Sotera Health to Showcase Continued Revenue Growth and Strategic Value Creation at 44th Annual J.P. Morgan Healthcare Conference
-
Surge Copper Appoints Jennifer Anthony as Vice President, Environment and Regulatory Affairs
-
Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Net Product Revenue
-
Precede Biosciences Secures $83.5M in Total Financing to Scale Next-Generation Precision Diagnostics Platform
-
Oruka Therapeutics Announces Positive Interim Phase 1 Data for ORKA-002 and Initiation of EVERLAST-B Trial of ORKA-001
-
Autolus Therapeutics Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Net Product Revenue, Pipeline Advancements and Outlook for 2026
-
Syndax Reports Preliminary 2025 Financial Highlights and Provides Business Updates at the 44th Annual J.P. Morgan Healthcare Conference
-
MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference
-
NewtekOne, Inc. Announces Extension of Exchange Offer for its Notes due 2026
-
Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025
-
KEY Investment Partners Acquires BellRock Brands’ Portfolio, Home of Mary’s Medicinals, Dixie and Other Top Names
-
Apellis Highlights Commercial Execution and Strategic Priorities at the 44th Annual J.P. Morgan Healthcare Conference
-
Five Below, Inc. Announces Holiday Sales Results for Quarter-To-Date Through January 3, 2026
-
Amplify ETFs Nominated for ETF Provider of the Year
-
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025
-
Oatly to Report Fourth Quarter 2025 Financial Results on February 11, 2026
-
GXO Schedules Fourth Quarter, Full-Year 2025 Earnings Conference Call for Wednesday, February 11, 2026
-
Village Farms International Advances New Product Innovation in the Dutch Market
-
Publication of Prospectus
-
Dimensional Fund Advisors Ltd. : Form 8.3 - UNITE GROUP PLC/THE - Ordinary Shares
-
YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
-
Aclaris Therapeutics Initiates Phase 1b Proof-of-Concept Trial in Atopic Dermatitis (AD) with Its Novel Bispecific Antibody ATI-052
-
Form 8.3 - [IDOX PLC - 09 01 2026] - (CGWL)
-
Pharvaris Outlines 2026 Strategic Priorities
-
ANI Pharmaceuticals Highlights Significant Growth in 2025, Provides 2026 Financial Guidance, and Outlines Strategic Priorities
-
DPM Metals Achieves Gold Production Guidance for the Eleventh Consecutive Year; Announces Timing of Fourth Quarter and Full-Year 2025 Financial Results
-
Scorpio Tankers Inc. Announces a Vessel Sale Agreement
-
DPM Metals Announces Filing of Technical Report for the Čoka Rakita Gold Project
-
Duolingo Announces CFO Transition
-
Supergasbras Modernizes Complex Gas Distribution Operations with Descartes Routing Solution
-
Inspire Medical Systems, Inc. Announces Preliminary Unaudited Revenue Results for the Fourth Quarter and Full Year 2025 and Provides Initial 2026 Revenue Guidance
-
Brookfield Corporation to Host Fourth Quarter 2025 Results Conference Call
